Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægerne Ravn ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   2.7% 1.9% 3.2% 2.7% 1.7% 1.9% 10.0% 10.0%   Credit score (0-100)   62 70 54 60 71 70 25 25   Credit rating   BBB A BBB BBB A A BB BB   Credit limit (kDKK)   0.0 3.0 0.0 0.0 8.2 2.5 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   17,111 17,677 21,733 21,483 20,441 22,526 0.0 0.0   EBITDA   4,802 4,789 7,204 6,358 3,298 2,963 0.0 0.0   EBIT   4,572 4,572 6,984 6,134 3,032 2,654 0.0 0.0   Pre-tax profit (PTP)   4,559.6 4,538.0 6,921.1 6,116.9 3,063.7 2,688.7 0.0 0.0   Net earnings   3,556.4 3,539.9 5,353.6 4,712.5 2,338.1 2,097.2 0.0 0.0   Pre-tax profit without non-rec. items   4,560 4,538 6,921 6,117 3,064 2,689 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   1,069 946 1,279 1,434 1,418 1,318 0.0 0.0   Shareholders equity total   5,190 5,173 6,987 6,346 3,972 3,731 1,506 1,506   Interest-bearing liabilities   262 88.8 0.0 0.0 249 200 0.0 0.0   Balance sheet total (assets)   7,008 8,589 10,603 9,493 6,854 5,932 1,506 1,506   Net Debt   -4,017 -6,116 -6,558 -6,117 -3,307 -3,015 -1,506 -1,506     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   17,111 17,677 21,733 21,483 20,441 22,526 0.0 0.0   Gross profit growth   -2.2% 3.3% 22.9% -1.2% -4.8% 10.2% -100.0% 0.0%   Employees   24 26 27 27 30 29 0 0   Employee growth %   -11.1% 8.3% 3.8% 0.0% 11.1% -3.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   7,008 8,589 10,603 9,493 6,854 5,932 1,506 1,506   Balance sheet change%   8.6% 22.6% 23.5% -10.5% -27.8% -13.5% -74.6% 0.0%   Added value   4,801.7 4,789.4 7,203.8 6,357.9 3,255.4 2,962.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -442 -341 113 -68 -283 -408 -1,318 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   26.7% 25.9% 32.1% 28.6% 14.8% 11.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   68.0% 58.7% 72.8% 61.3% 37.5% 42.1% 0.0% 0.0%   ROI %   85.8% 83.0% 112.8% 91.4% 57.1% 64.7% 0.0% 0.0%   ROE %   70.6% 68.3% 88.1% 70.7% 45.3% 54.5% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   76.4% 61.7% 66.9% 68.1% 59.5% 65.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -83.7% -127.7% -91.0% -96.2% -100.3% -101.8% 0.0% 0.0%   Gearing %   5.1% 1.7% 0.0% 0.0% 6.3% 5.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   13.0% 22.1% 136.0% 0.0% 0.0% 0.1% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   3.9 2.2 2.5 2.5 1.8 2.0 0.0 0.0   Current Ratio   3.7 2.2 2.6 2.6 1.9 2.1 0.0 0.0   Cash and cash equivalent   4,279.3 6,204.4 6,557.5 6,117.4 3,556.1 3,214.5 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   4,238.8 4,154.8 5,644.0 4,857.3 2,491.3 2,337.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   200 184 267 235 109 102 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   200 184 267 235 110 102 0 0   EBIT / employee   190 176 259 227 101 92 0 0   Net earnings / employee   148 136 198 175 78 72 0 0